Conclusion: complaint not confirmed for leak as the product was not returned and no pictures were provided by the customer.The description of the leak was not clear enough to understand where the leak occurred and root cause can not be determined with the information provided.No lot or serial number were provided, therefore the device history record was not reviewed as no lot or serial number were provided, however devices are required to pass manufacturing inspections prior to release.There were no patient/clinical safety issues reported.Trends for issues with this product are reviewed at quarterly quality meetings.This regulatory report is being submitted as part of a retrospective review and remediation per d00953163 as part of a capa action.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
Medtronic received information that during use of a fusion oxygenator during a veno-arterial extracorporeal membrane oxygenation (v-a ecmo) bypass surgery, the customer reported that there was a little blood extravasation on the surface of the oxygenator.Thirty minutes after the start of the surgery, the blood extravasation of the oxygenator from cracks increased significantly.The amount of patient blood loss as a result of this leak was not large.Five minutes later, the device was urgently replaced with another extracorporeal circulation kit.The physician closely monitored the changes in the patient's vital signs, emergency blood matching and blood transfusion and other rescue measures.The patient's own condition needed a relatively large amount of blood transfusion, which had little to do with membrane lung leakage.Additional information: there was no damage to any other parts of the device, the packaging or other contents within the package.There was no air in the system/tubing.
|